On April 25, 2003, the United States Department of Health and Human Services Centers for Disease Control and Prevention (hereinafter, “CDC”) filed an application for a United States patent (Application Number US46592703P, subsequently issued as U.S. Patent 7,776,521 and U.S. Patent 7,220,852) entitled “Coronavirus isolated from humans”. Claim 3 –A method of detecting a severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in a sample…; and, Claim 4 - A kit for detecting a severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in a sample…, provided the CDC with a statutory market exclusion right the detection of and sampling for severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Securing this right afforded the CDC exclusive right to research, commercially exploit, or block others from conducting activities involving SARS-CoV. On September 24, 2018, the CDC failed to pay the required maintenance fees on this patent and their rights expired.

www.wethepeople.buzz